NEW YORK – Bausch + Lomb has launched a new public service announcement and docu-series to raise awareness of age-related macular degeneration (AMD), a leading cause of vision loss in people ages 50 and older.
Opioid abuse is a serious public health problem that has reached crisis levels across the United States, with more than 90 Americans dying each day from overdose of opioids, and many more becoming addicted.
eRx Network announced today that Ashton Maaraba has joined the company as senior vice president, product and partnerships effective immediately.
Osteo Bi-Flex has announced a partnership with world renowned, seven-time No. 1 professional tennis player Chris Evert. Together with Osteo Bi-Flex, Evert will help reinforce the brand’s commitment to leading the call for movement.
TUKWILA, Wash.– Genoa, a QoL Healthcare Company, the nation’s leading behavioral health pharmacy and largest outpatient telepsychiatry company, today announced an organizational rebrand as well as a new name, Genoa Healthcare.
Bartell Drugs is highlighting locally and regionally based companies and their products during its third annual “Loving Local” week from February 4 – February 10.
Amneal Pharmaceuticals has launched isotretinoin capsules, USP, an AB-rated generic for Accutane used to treat severe recalcitrant nodular acne in 10 mg, 20 mg, 30 mg and 40 mg. The product is available in cartons containing 3 blister packs of 10 capsules each and it began shipping today.
Henkel recently held ribbon cutting ceremonies at two new research and development facilities in Trumbull and Stamford.
RIDGEFIELD, Conn.– Boehringer Ingelheim announced that its U.S. president and chief executive officer Paul Fonteyne will retire and Wolfgang Baiker has been appointed to succeed him, effective March 1. The position will be based at the pharmaceutical company’s U.S. headquarters in Ridgefield.
NEW YORK– Revlon announced that Fabian Garcia, president and chief executive officer of Revlon, has stepped down from his position to pursue other opportunities.
Eosera Inc. has announced that the company will expand its manufacturing capabilities and retail distribution, as well as launch a new ear care product line this year.
CutisPharma reported that the U.S. Food and Drug Administration has approved Firvanq (vancomycin hydrochloride) for oral solution, for the treatment of Clostridium difficile associated diarrhea and enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains.
As vinyl records continue to make a comeback, Hallmark Cards Inc. is releasing what it calls the first-ever vinyl record cards this Valentine’s Day.
The Network of Executive Women has appointed a new board chair and seven new members to its board of directors.
WASHINGTON – The Pharmacy Technician Certification Board (PTCB) announced two significant changes to its Certified Pharmacy Technician (CPhT) Program that will take effect on Jan. 1, 2020.
AstraZeneca announced that Bydureon BCise (exenatide extended-release injectable suspension 2 mg) is now available in pharmacies across the United States. Bydureon BCise was recently approved by the U.S.
